Fidelity Investments
NXL icon

Fidelity Investments’s Nexalin Technology NXL Stock Holding History

Fidelity Investments’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522 Sell
1,500
-30,125
-95% -$15.7K ﹤0.01% 5159
2025
Q4 		$17.6K Buy
31,625
+30,225
+2,159% +$34K ﹤0.01% 4518
2025
Q3 		$1.28K Buy
1,400
+1,300
+1,300% +$1.23K ﹤0.01% 4990
2025
Q2 		$102 Buy
+100
New +$140 ﹤0.01% 5135

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments's NXL Position: Q1 2026 in Review

Fidelity Investments reduced its Nexalin Technology (NXL) stake by 95% in Q1 2026, selling an estimated $15.7K and leaving 1,500 shares worth $522. The position accounts for ﹤0.01% of the portfolio, ranked #5159.

Fidelity Investments first reported a position in NXL in Q2 2025 and has held it in 4 quarters since. The position peaked at $17.6K in Q4 2025. 23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

  • Fidelity Investments held 1,500 shares of Nexalin Technology worth $522 as of Q1 2026.
  • Fidelity Investments sold 30,125 Nexalin Technology shares in Q1 2026, an estimated $15.7K.
  • Nexalin Technology made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5159 holding.
  • Fidelity Investments first reported a position in Nexalin Technology in Q2 2025 and has held it in 4 quarters since.
  • Fidelity Investments's Nexalin Technology position peaked at $17.6K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.